Research programme: vitamin A signal amplifiers - OPKO Health

Drug Profile

Research programme: vitamin A signal amplifiers - OPKO Health

Alternative Names: Vitamin A signal amplifiers research programme - Cytochroma

Latest Information Update: 08 Mar 2013

Price : $50

At a glance

  • Originator Cytochroma
  • Class
  • Mechanism of Action Retinoic acid metabolism modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 08 Mar 2013 Discontinued - Preclinical for Cancer in USA (unspecified route)
  • 04 Mar 2013 OPKO Health acquires Cytochroma
  • 22 Jul 2004 Preclinical trials in Cancer in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top